BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10931169)

  • 1. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
    Churn M; Clough V
    Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
    Syed NN; Khurshid M
    J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
    Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
    Montillo M; Tedeschi A; Leoni P
    Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Hegde UP; Wilson WH; White T; Cheson BD
    Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
    Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
    Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
    Vidarsson B; Mosher DF; Salamat MS; Isaksson HJ; Onundarson PT
    Am J Hematol; 2002 May; 70(1):51-4. PubMed ID: 11994982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
    Byrd JC; Hertler AA; Weiss RB; Freiman J; Kweder SL; Diehl LF
    Ann Oncol; 1995 Mar; 6(3):300-1. PubMed ID: 7612497
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    Field K; Slavin MA; Seymour JF
    Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
    Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
    Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.